Klick’s latest health tech uses a person’s voice and artificial intelligence to detect diabetesnews2023-10-18T11:04:32+00:00October 18th, 2023|Endpoints News|
UCB’s Bimzelx and Zilbrysq win US approval for blockbuster plaque psoriasis and gMG indications, respectivelynews2023-10-18T11:00:06+00:00October 18th, 2023|Endpoints News|
Takeda’s stem cell therapy Alofisel fails PhIII trial investigating the drug in Crohn’s diseasenews2023-10-18T10:54:17+00:00October 18th, 2023|Endpoints News|
Carl Icahn sues Illumina board members over Grail acquisitionnews2023-10-18T08:38:53+00:00October 18th, 2023|Endpoints News|
FDA approves new indication for Ardelyx’s tenapanor for serum phosphorus controlnews2023-10-17T23:18:16+00:00October 17th, 2023|Endpoints News|
Eli Lilly to acquire European ADC biotech Mablinknews2023-10-17T22:25:03+00:00October 17th, 2023|Endpoints News|
FDA approves Merck’s Keytruda for before and after lung cancer surgerynews2023-10-17T20:14:56+00:00October 17th, 2023|Endpoints News|
Rhythm’s drug shows 25% drop in BMI for patients with rare form of obesity in small studynews2023-10-17T20:00:52+00:00October 17th, 2023|Endpoints News|
ESMO embargo break leads cancer conference to release data for Bristol Myers, J&J, Novartis, AstraZenecanews2023-10-17T19:53:59+00:00October 17th, 2023|Endpoints News|
US vs. Europe: New research paper compares drug review times across bordersnews2023-10-17T19:15:00+00:00October 17th, 2023|Endpoints News|
